pentamidine has been researched along with Disease, Pulmonary in 7 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In order to determine the possible effect of aerosolized pentamidine on the cellular composition of the bronchoalveolar lavage fluid in HIV-infected patients, differential counts of 22 consecutive patients who had been rebronchoscopied after 3-19 months were reviewed." | 7.68 | Pentamidine aerosol increases the number of alveolar macrophages in HIV-infected patients. ( Don, M; Eckert, G; Hilger, HH; Pothoff, G; Schell-Frederick, E; Wassermann, K, 1991) |
| " Well-controlled studies of aerosolized antibiotics in cystic fibrosis demonstrate that tobramycin on a cyclical basis may reduce sputum volume, bacterial counts, and improve pulmonary function." | 4.80 | Inhaled antimicrobial therapy. ( Faris, M; O'Riordan, T, 1999) |
| "In order to determine the possible effect of aerosolized pentamidine on the cellular composition of the bronchoalveolar lavage fluid in HIV-infected patients, differential counts of 22 consecutive patients who had been rebronchoscopied after 3-19 months were reviewed." | 3.68 | Pentamidine aerosol increases the number of alveolar macrophages in HIV-infected patients. ( Don, M; Eckert, G; Hilger, HH; Pothoff, G; Schell-Frederick, E; Wassermann, K, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murray, JF | 1 |
| Felton, CP | 1 |
| Garay, SM | 1 |
| Gottlieb, MS | 2 |
| Hopewell, PC | 1 |
| Stover, DE | 1 |
| Teirstein, AS | 1 |
| Tu, JV | 1 |
| Biem, HJ | 1 |
| Detsky, AS | 1 |
| Gracia, JD | 1 |
| Miravitlles, M | 1 |
| Mayordomo, C | 1 |
| Ferrer, A | 1 |
| Alvárez, A | 1 |
| Bravo, C | 1 |
| Vendrell, M | 1 |
| O'Riordan, T | 1 |
| Faris, M | 1 |
| Rosenthal, GJ | 1 |
| Craig, WA | 1 |
| Corsini, E | 1 |
| Taylor, M | 1 |
| Luster, MI | 1 |
| Wassermann, K | 1 |
| Schell-Frederick, E | 1 |
| Eckert, G | 1 |
| Don, M | 1 |
| Pothoff, G | 1 |
| Hilger, HH | 1 |
1 review available for pentamidine and Disease, Pulmonary
| Article | Year |
|---|---|
Inhaled antimicrobial therapy.
Topics: Administration, Inhalation; Aerosols; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; | 1999 |
6 other studies available for pentamidine and Disease, Pulmonary
| Article | Year |
|---|---|
Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop.
Topics: Acquired Immunodeficiency Syndrome; Biopsy; Bronchoscopy; Cytomegalovirus Infections; Drug Combinati | 1984 |
Pulmonary disease in the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Female; Humans; Lung Diseases; Lung Diseases, | 1984 |
Bronchoscopy versus empirical therapy in HIV-infected patients with presumptive Pneumocystis carinii pneumonia. A decision analysis.
Topics: AIDS-Related Opportunistic Infections; Biopsy; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoscopy; | 1993 |
Empiric treatments impair the diagnostic yield of BAL in HIV-positive patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifung | 1997 |
Pentamidine blocks the pathophysiologic effects of endotoxemia through inhibition of cytokine release.
Topics: Animals; Cytokines; Endotoxins; Escherichia coli; Female; Hypothermia; Interleukin-6; Lung; Lung Dis | 1992 |
Pentamidine aerosol increases the number of alveolar macrophages in HIV-infected patients.
Topics: Administration, Inhalation; Adult; Aerosols; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cell Count; | 1991 |